Business
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
Video featuring Mr. John Sutcliffe, Lead Clinician at The London Spine Clinic, highlights real-world physician experience with Nociscan in clinical
About this update from Aclarion, Inc.
[{"type":"text","content":"Video featuring Mr. John Sutcliffe, Lead Clinician at The London Spine Clinic, highlights real-world physician experience with Nociscan in clinical practiceNearly 100 Nociscans performed at The London Clinic, reflecting increasing utilization for evaluation of chronic low back pain BROOMFIELD, Colo., April 07, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the release of a new video featuring Mr. John Sutcliffe, Consultant Spinal Neurosurgeon at The London Clinic, one of the United Kingdom’s leading private hospitals. The video is available here. With more than 30 years of experience in treating patients with all types of spinal conditions, including back and neck pain, Mr. Sutcliffe also serves as the Lead Clinician at The London Spine Clinic and is frequently referred complex spinal cases for assessment and treatment. The video highlights his experience using Nociscan to evaluate patients with chronic low back pain. “Nociscan provides an additional layer of insight that complements traditional imaging,” said Mr. Sutcliffe. “Having more objective data can help inform clinical decisions and improve confidence when evaluating patients with chronic low back pain.” To date, nearly 100 Nociscans have been conducted at The London Clinic. Nociscan is a non-invasive solution that helps physicians differentiate between painful and non-painful discs in the lumbar spine by leveraging MR spectroscopy and proprietary signal processing to identify chemical biomarkers associated with disc pain. The continued use of Nociscan at The London Clinic reflects sustained physician engagement and growing integration of Nociscan into routine clinical practice. “This video offers a compelling perspective on how Nociscan is being used in day-to-day clinical practice,” said Brent Ness, Chief Executive Officer of Aclarion. “Approaching 100 scans at a leading international center like The London Clinic is an important indicator of increasing adoption and reinforces the potential for Nociscan to become a valuable tool in the evaluation of chronic low back pain.” Chronic low back pain is a significant global...